Education
About Us
Working with TipRanks
Follow Us
David Hung Insider Profile
11 Followers
David Hung, President & CEO, Director at Medivation, holds 59.28M shares in Nuvation Bio (Ticker: NUVB), holds 23.41K shares in NovoCure (Ticker: NVCR), holds 0.00 shares in Sio Gene Therapies (Ticker: SIOX). Most recently, David Hung Bought ― shares of Nuvation Bio on Jun 18, 2025 for an estimated value of 890.00K.
David Hung Medivation (MDVN)President & CEO, Director
Medivation (MDVN)
President & CEO, Director
Ranked #52,743 out of 102,596 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
-0.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Hung holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Hung
David Hung's Trading History
Medivation
Sep 30, 2016
―
Uninformative Sell
―
$133.32M
Sio Gene Therapies
Apr 19, 2017
―
Informative Buy
10.00M
$0.00
NovoCure
Jun 06, 2025
Director
Uninformative Buy
―
$293.56K
Establishment Labs Holdings
―
Director
―
―
ARYA Sciences Acquisition
―
―
―
―
Nuvation Bio
Jun 18, 2025
President & CEO, Director, Ten Percent Owner
Informative Buy
890.00K
$148.80M
Acer Therapeutics
Sep 10, 2009
―
Informative Sell
84.44K
$0.00
List of latest transactions for each holding click on a transaction to see David Hung's performance on stock
You May Also Like
David Hung insider profile FAQ
What is the percentage of profitable transactions made by David Hung?
The percentage of profitable transactions made by David Hung is 75%.
What is the average return per transaction made by David Hung?
The average return per transaction made by David Hung is -0.80%.
What stocks does David Hung hold?
David Hung holds: MDVN, SIOX, NVCR, ESTA, ~ARYA, NUVB, ACER stocks.
What was David Hung’s latest transaction?
David Hung latest transaction was an Informative Buy of $890.00K.
What was David Hung's most profitable transaction?
David Hung’s most profitable transaction was an Informative Buy of NUVB stock on April 8, 2025. The return on the trade was 38.50%.
What is David Hung's role in Medivation?
David Hung's role in Medivation is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.